Quentin Blackford serves as the President and Chief Executive Officer of iRhythm Technologies, Inc., a leading digital health company focused on advancing cardiac care through innovative technology. With a robust background in the medical device and healthcare industries, Blackford brings a wealth of experience and leadership to his role. Before joining iRhythm, he held several high-level positions, including President and CEO of Tandem Diabetes Care, where he played a pivotal role in the company's growth and development. His tenure at Tandem saw significant advancements in insulin delivery systems, contributing to improved patient outcomes and increased market share. At iRhythm Technologies, Blackford has been instrumental in steering the company towards its mission of improving arrhythmia detection and patient care. Under his leadership, iRhythm has expanded its product offerings and strengthened its position in the digital health space. One of the company's flagship products, the Zio XT, a long-term continuous monitoring system, has been widely adopted for its effectiveness in diagnosing cardiac arrhythmias. Blackford's strategic vision has also led to key partnerships and collaborations that have enhanced iRhythm's capabilities and reach. His commitment to innovation and patient-centric solutions continues to drive the company's success and growth. In addition to his professional achievements, Blackford is recognized for his contributions to the broader healthcare community. He actively participates in industry conferences and forums, sharing insights and advocating for advancements in healthcare technology. His leadership style emphasizes transparency, collaboration, and a relentless focus on improving patient care, which has earned him respect and admiration from colleagues and peers. As iRhythm Technologies continues to evolve and expand, Blackford's role as President and CEO remains crucial in navigating the company through the dynamic landscape of digital health.